UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity Journal article
Zhang, Haiyan, Luo, Xiaojing, Yang, Wei, Wu, Zhiying, Zhao, Zhicong, Pei, Xin, Zhang, Xue, Chen, Chonghao, Lei, Josh Haipeng, Shi, Qingxia, Zhao, Qi, Chen, Yanxing, Wu, Wenwei, Zeng, Zhaolei, Ju, Huai Qiang, Qiu, Miaozhen, Liu, Jun, Shen, Bin, Chen, Minshan, Chen, Jianjun, Deng, Chu Xia, Xu, Rui Hua, Hou, Jiajie. YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity[J]. Nature Communications, 2024, 15(1), 9559.
Authors:  Zhang, Haiyan;  Luo, Xiaojing;  Yang, Wei;  Wu, Zhiying;  Zhao, Zhicong; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:14.7/16.1 | Submit date:2024/12/05
TRIM59 guards ER proteostasis and prevents Bortezomib-mediated colorectal cancer (CRC) cells’ killing Journal article
Xuejia Feng, Gui Yang, Litian Zhang, Shishi Tao, Joong Sup SHIM, Liang Chen, Qingxia Wu. TRIM59 guards ER proteostasis and prevents Bortezomib-mediated colorectal cancer (CRC) cells’ killing[J]. INVESTIGATIONAL NEW DRUGS, 2022, 40(6), 1244-1253.
Authors:  Xuejia Feng;  Gui Yang;  Litian Zhang;  Shishi Tao;  Joong Sup SHIM; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:3.0/2.9 | Submit date:2023/01/30
Trim59  Er-stress  Unfolded Protein Response  Er-associated Degradation  Bortezomib  Colorectal Cancer